These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36338728)

  • 1. Research on the effects of rs1800566 C/T polymorphism of NAD(P)H quinone oxidoreductase 1 gene on cancer risk involves analysis of 43,736 cancer cases and 56,173 controls.
    Zhou H; Wan H; Zhu L; Mi Y
    Front Oncol; 2022; 12():980897. PubMed ID: 36338728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
    Zhang H; Wen X; Lu X; Zhang H
    Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis.
    Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H
    Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
    Yang S; Zhao J; Li L
    Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
    Ding R; Lin S; Chen D
    Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
    Guo ZJ; Feng CL
    Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
    Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
    Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
    Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
    Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
    Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
    J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
    Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
    Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
    Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
    Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.
    Yu H; Liu H; Wang LE; Wei Q
    PLoS One; 2012; 7(1):e30566. PubMed ID: 22272361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis.
    Zhang Q; Zheng M; Qi XL; Liu F; Mao ZJ; Zhang DH
    Onco Targets Ther; 2014; 7():907-14. PubMed ID: 24940075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Polymorphism of NQO1 Gene is Associated with Susceptibility of Ischemic Stroke in Chinese Han Nationality.
    Yan L; Xu D; Xiao Y; Dai M; Wang T; Zhuang X; Wu K
    Neuropsychiatr Dis Treat; 2022; 18():2211-2217. PubMed ID: 36196359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
    Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
    J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association of NAD(P)H quinone oxidoreductase (NQO1*2) polymorphism with NQO1 levels and risk of diabetic nephropathy.
    Sharma M; Mehndiratta M; Gupta S; Kalra OP; Shukla R; Gambhir JK
    Biol Chem; 2016 Aug; 397(8):725-30. PubMed ID: 27078674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of
    Tian L; Xiao P; Zhou B; Chen Y; Kang L; Wang Q; Lin J; Son M; Wu Q
    Cardiovasc Ther; 2021; 2021():5534946. PubMed ID: 34457036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.
    Lajin B; Alachkar A
    Br J Cancer; 2013 Sep; 109(5):1325-37. PubMed ID: 23860519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.